Literature DB >> 2595036

Chronic obstructive airways disease following treated pulmonary tuberculosis.

P A Willcox1, A D Ferguson.   

Abstract

Seventy-one subjects who had previously been treated for tuberculosis up to 16 years before underwent pulmonary function assessment. Evidence of airways obstruction was found in 48 (68%). There was an inverse relationship between the extent of the disease on the original chest radiograph and the forced expired volume in one second (FEV1). A similar inverse relationship between the amount of sputum produced and the FEV1 and the original chest radiograph was also found. Treated pulmonary tuberculosis is a cause of significant chronic obstructive airways disease.

Entities:  

Mesh:

Year:  1989        PMID: 2595036     DOI: 10.1016/s0954-6111(89)80031-9

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  56 in total

Review 1.  Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD.

Authors:  R N van Zyl Smit; M Pai; W W Yew; C C Leung; A Zumla; E D Bateman; K Dheda
Journal:  Eur Respir J       Date:  2010-01       Impact factor: 16.671

2.  Influence of old pulmonary tuberculosis on the management of secondary spontaneous pneumothorax in patients over the age of 70 years.

Authors:  Sang Cjeol Lee; Deok Heon Lee
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

Review 3.  The convergence of the global smoking, COPD, tuberculosis, HIV, and respiratory infection epidemics.

Authors:  Richard N van Zyl-Smit; Laurence Brunet; Madhukar Pai; Wing-Wai Yew
Journal:  Infect Dis Clin North Am       Date:  2010-09       Impact factor: 5.982

4.  Toll-like Receptor 2 Prevents Neutrophil-Driven Immunopathology during Infection with Mycobacterium tuberculosis by Curtailing CXCL5 Production.

Authors:  Archana Gopalakrishnan; Jillian Dietzold; Sheetal Verma; Madhuri Bhagavathula; Padmini Salgame
Journal:  Infect Immun       Date:  2019-02-21       Impact factor: 3.441

5.  Longevity loss among cured tuberculosis patients and the potential value of prevention.

Authors:  S Hoger; K Lykens; S F Beavers; D Katz; T L Miller
Journal:  Int J Tuberc Lung Dis       Date:  2014-11       Impact factor: 2.373

6.  Clinico-Radiologic and Spirometric Profile of an Indian Population with Post-Tuberculous Obstructive Airway Disease.

Authors:  Avradip Santra; Pravati Dutta; Rekha Manjhi; Sudarsan Pothal
Journal:  J Clin Diagn Res       Date:  2017-03-01

Review 7.  Advancing host-directed therapy for tuberculosis.

Authors:  Robert S Wallis; Richard Hafner
Journal:  Nat Rev Immunol       Date:  2015-03-13       Impact factor: 53.106

8.  Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; V N Maturu; Sahajal Dhooria; K T Prasad; Inderpaul S Sehgal; Lakshmikant B Yenge; Aditya Jindal; Navneet Singh; A G Ghoshal; G C Khilnani; J K Samaria; S N Gaur; D Behera
Journal:  Lung India       Date:  2013-07

Review 9.  Convergence of non-communicable diseases and tuberculosis: a two-way street?

Authors:  M J Magee; A D Salindri; U P Gujral; S C Auld; J Bao; J S Haw; H-H Lin; H Kornfeld
Journal:  Int J Tuberc Lung Dis       Date:  2018-11-01       Impact factor: 2.373

10.  Alterations in the peripheral blood B cell subpopulations of multidrug-resistant tuberculosis patients.

Authors:  Mónica T Abreu; Helena Carvalheiro; Tiago Rodrigues-Sousa; António Domingos; António Segorbe-Luis; Paulo Rodrigues-Santos; M Margarida Souto-Carneiro
Journal:  Clin Exp Med       Date:  2013-09-26       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.